Clinical Trial

Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 2, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Pathogenic variants in subcortical maternal complex (SCMC) have been identified not only in mothers of Beckwith-Wiedemann syndrome (BWS) babies but also in women with reproductive disturbances such as failed pregnancy attempts and recurrent pregnancy loss. Based on the higher incidence of BWS in children born from Assisted Reproductive Technology (ART), this project aims to investigate incidence and molecular mechanism of pathogenic variants of SCMC in women with reproductive disorders. Study objectives will be (i) assess the incidence of these variants as a cause of differences in reproductive outcomes in the infertile female population and mothers of children with BWS; (ii) identify methylation changes in women with reproductive problems including those with offspring affected by BWS; (iii) determine the molecular causes underlying female infertility and imprinting disorder associated with damaging SCMC gene variants by employing a mouse model.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-28.
Trial Details
NCT Number NCT06346418
Lead Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators: Istituto Auxologico Italiano, University of Campania Luigi Vanvitelli, Federico II University
Conditions Beckwith-Wiedemann Syndrome
Enrollment 208 participants
Start Date 2023-05-19
Primary Completion 2025-12 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-02